Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer.

Yesterday, April 28, 2015, 56 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $625.00 to $2,071,840.58.

Highlighted Stocks Traded by Insiders:

KMG Chemicals (KMG) - FREE Research Report

Hatcher David L, who is 10% Owner at KMG Chemicals, sold 1,500 shares at $30.54 on April 28, 2015. Following this transaction, the 10% Owner owned 2.0 million shares meaning that the stake was reduced by 0.08% with the 1,500-share transaction.

The shares most recently traded at $30.79, up $0.25, or 0.8% since the insider transaction. Historical insider transactions for KMG Chemicals go as follows:

  • 4-Week # shares bought: 3,000
  • 4-Week # shares sold: 19,500
  • 12-Week # shares bought: 3,000
  • 12-Week # shares sold: 24,500
  • 24-Week # shares bought: 3,000
  • 24-Week # shares sold: 24,500

The average volume for KMG Chemicals has been 56,300 shares per day over the past 30 days. KMG Chemicals has a market cap of $357.0 million and is part of the basic materials sector and chemicals industry. Shares are up 54.6% year-to-date as of the close of trading on Tuesday.

KMG Chemicals, Inc., through its subsidiaries, engages in the manufacture, formulation, and distribution of specialty chemicals in the United States, Mexico, Canada, Europe, Israel, and Singapore. It operates in two segments, Electronic Chemicals and Wood Treating Chemicals. The stock currently has a dividend yield of 0.39%. The company has a P/E ratio of 50.9. Currently, there is 1 analyst who rates KMG Chemicals a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on KMG - FREE

TheStreet Quant Ratings

rates KMG Chemicals as a

buy

. The company's strengths can be seen in multiple areas, such as its compelling growth in net income, largely solid financial position with reasonable debt levels by most measures, expanding profit margins, solid stock price performance and impressive record of earnings per share growth. We feel these strengths outweigh the fact that the company shows weak operating cash flow. Get the full

KMG Chemicals Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

EVINE Live (EVLV) - FREE Research Report

Ge Capital Equity Investments Inc, who is Shareholder at EVINE Live, sold 23,023 shares at $6.29 on April 28, 2015. Following this transaction, the Shareholder owned 3.6 million shares meaning that the stake was reduced by 0.63% with the 23,023-share transaction.

The shares most recently traded at $6.26, down $0.03, or 0.43% since the insider transaction. Historical insider transactions for EVINE Live go as follows:

  • 4-Week # shares bought: 5,500
  • 4-Week # shares sold: 91,512
  • 12-Week # shares bought: 5,500
  • 12-Week # shares sold: 91,512
  • 24-Week # shares bought: 5,500
  • 24-Week # shares sold: 678,693

The average volume for EVINE Live has been 224,900 shares per day over the past 30 days. EVINE Live has a market cap of $356.9 million and is part of the services sector and retail industry. Shares are down 4.1% year-to-date as of the close of trading on Tuesday.

EVINE Live Inc. operates as a digital commerce company in the United States. Currently, there are 6 analysts who rate EVINE Live a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on EVLV - FREE

TheStreet Quant Ratings

rates EVINE Live as a

sell

. The company's weaknesses can be seen in multiple areas, such as its weak operating cash flow and poor profit margins. Get the full

EVINE Live Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Tiptree Financial (TIPT) - FREE Research Report

Barnes Michael Gene, who is Executive Chairman at Tiptree Financial, bought 5,509 shares at $6.64 on April 28, 2015. Following this transaction, the Executive Chairman owned 1.2 million shares meaning that the stake was boosted by 0.46% with the 5,509-share transaction.

The shares most recently traded at $6.81, up $0.17, or 2.49% since the insider transaction. Historical insider transactions for Tiptree Financial go as follows:

  • 4-Week # shares bought: 42,398
  • 12-Week # shares bought: 87,275
  • 24-Week # shares bought: 126,075

The average volume for Tiptree Financial has been 18,600 shares per day over the past 30 days. Tiptree Financial has a market cap of $212.7 million and is part of the financial sector and insurance industry. Shares are down 17.9% year-to-date as of the close of trading on Tuesday.

TipTree Financial Inc., formerly Care Investment Trust, operates as a real estate investment trust (REIT). It engages in originating and acquiring healthcare-related real estate and commercial mortgage debt.

Exclusive Offer: Get the latest Stock Analysis on TIPT - FREE

TheStreet Quant Ratings

rates Tiptree Financial as a

sell

. The company's weaknesses can be seen in multiple areas, such as its deteriorating net income, generally high debt management risk and generally disappointing historical performance in the stock itself. Get the full

Tiptree Financial Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

null